Destigmatizing Urology: Dr. Amarasekera discusses sexual minorities in urology

"Augmented biopsy-based and noninvasive options are available to reduce benign resection rates of renal tumors with the consideration of PEER and 99mTc-sestamibi SPECT/CT," writes Hiten D. Patel, MD, MPH.

"I think there's a lot of fear that can go into talking about these topics," says Katherine Rotker, MD.

In this interview, Ziho Lee, MD, discusses the buccal mucosa graft for urethral and ureteral stricture disease.

"Hopefully, this will be a resource for people who are preparing for birth, or who have recently experienced birth," says Linda Brubaker, MD, MS.

In an interview during the 2022 LUGPA Annual Meeting, Ashley Ross, MD, PhD, discussed angoing advances and unmet needs in prostate cancer.

Research findings suggest that SLIT2 loss in circulating tumor cells promotes metastasis and enhances cancer progression, according to a Northwestern Medicine study published in Science Advances.